AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2016
May 27, 2016
29875_dirs_2016-05-27_d01091c7-a7e9-4e89-ace8-2e7417e5024b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2016-04-01
Reporting Person: Foulkes Helena (EVP, President-CVS Pharmacy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-01 | Common Stock | F | 2199 | $104.82 | Disposed | 43495.8095 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (pep) | 0 | Direct |
| Common Stock (restricted) | 41172 | Direct |
| Stock Unit | 35293.2299 | Direct |
Footnotes
F1: The purpose of this Amended Form 4/A is to correct the number of surrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards, one of which was deferred, and to correct the resulting share balances in the reporting person's accounts.
F2: Corrects the share balance of Common Stock.
F3: Corrects the share balance of Common Stock (pep).
F4: Corrects the share balance of Common Stock (restricted).
F5: Corrects the share balance of Stock Units (deferred).
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3